Related Experiment Videos
Secondary diabetic complications and biochemical parameters
1Department of Physiology, Faculty of Medicine, Great Al-Fateh University of Medical Sciences, Tripoli, Libya.
Indian Journal of Medical Sciences
|November 1, 1990
Summary
Libyan diabetic patients with secondary complications show higher levels of various biomarkers and vital signs. However, those without complications have higher fasting blood glucose and cholesterol, with longer diabetes duration in complicated cases.
Area of Science:
- Endocrinology and Metabolism
- Clinical Biochemistry
Background:
- Diabetes mellitus is a chronic metabolic disorder with potential for severe secondary complications.
- Understanding biomarker variations in diabetic patients with and without complications is crucial for risk stratification and management.
Purpose of the Study:
- To compare biochemical and physiological parameters between Libyan diabetic patients with and without secondary complications.
- To investigate the relationship between diabetes duration and the presence of secondary complications.
Main Methods:
- Comparative analysis of mean values for body mass index, hemoglobin A1, serum protein, lipids, enzymes, and cardiovascular markers.
- Statistical comparison between two groups: diabetic patients with secondary complications and those without.
- Assessment of diabetes duration in both patient groups.
Main Results:
- Significantly higher mean levels of body mass index, hemoglobin A1, serum protein, triglycerides, lactate dehydrogenase, alkaline phosphatase, amylase, beta-glucuronidase, heart rate, blood pressure, and blood urea in patients with secondary complications.
- Conversely, patients without complications exhibited higher mean levels of fasting blood glucose, serum cholesterol, and beta-N-acetylglucosaminidase.
- The mean duration of diabetes was notably longer in patients with secondary complications (10.2 years) compared to those without (5.2 years).
Conclusions:
- Distinct biomarker profiles differentiate Libyan diabetic patients with and without secondary complications.
- Longer diabetes duration is strongly associated with the development of secondary complications.
- These findings highlight the importance of monitoring specific biomarkers and managing diabetes duration to prevent complications.